De novo antibody protein sequencing reveals novel functional and neutralizing antibodies post-SARS-CoV-2 vaccination

Rapid Novor has published a study that highlights the power of combining de novo antibody protein sequencing with conventional proteomics to uncover functional and neutralizing antibodies in human plasma following SARS-CoV-2 vaccination.

Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

April 10, 2024

Hospitals Say Some Medicare Advantage Plans Are Skirting CMS Rules

Some Medicare Advantage (MA) plans do not intend to abide by the 2024 CMS rule that prohibits them from denying coverage of services that traditional

November 28, 2023

Magazine: US reproductive laws could limit women’s participation in clinical trials – Pharmaceutical Technology

Two years have passed since the US Supreme Court’s decision in Dobbs vs Jackson Women’s Health to overturn the constitutional protection for abortion rights. With

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.